-
Regeneron Pharmaceuticals' (REGN) Overweight Rating Reiterated at Wells Fargo & Company
Source: Buzz FX / 23 Sep 2024 15:52:10 America/New_York
Regeneron Pharmaceuticals' (REGN) Overweight Rating Reiterated at Wells Fargo & Company Written by MarketBeat September 23, 2024 Share Link copied to clipboard. Regeneron Pharmaceuticals ( NASDAQ:REGN - Get Free Report ) 's stock had its "o
Read more...